Clinical effectiveness study of the artificial pancreas system (APS) in patients with type 1 diabetes mellitus
Likarska sprava · 27.04.2026 · (2)
DOI: 10.31640/ls-2026-2-03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Likarska sprava, online erschienen am 27.04.2026. Verfasst von T. I. Крицький. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 1 diabetes mellitus remains a major clinical challenge due to difficulties in achieving stable glycemic control and preventing acute and chronic complications. Automated insulin delivery systems are considered a promising approach to optimize diabetes management.
Objective
To evaluate the clinical efficacy and safety of an artificial pancreas system compared with conventional insulin pump therapy in patients with type 1 diabetes.
Methods
A comparative parallel-group clinical study included 50 patients aged 18–45 years. Twenty-five participants used APS and 25 received conventional insulin pump therapy. The follow-up period was 6 months. Primary endpoints were HbA1c and Time in Range (TIR 3.9–10.0 mmol/L). Secondary endpoints included hypoglycemia frequency, glycemic variability (SD), and quality of life assessed by the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Statistical analysis was performed using Student’s t-test.
Results
After 6 months, HbA1c decreased from 8.1 ± 0.6% to 6.9 ± 0.5% in the APS group and from 8.0 ± 0.7% to 7.6 ± 0.6% in the conventional pump group (p < 0.01). TIR was significantly higher in the APS group (78 ± 6%) compared with controls (62 ± 8%; p < 0.001). Hypoglycemia frequency was lower in the APS group (1.2 ± 0.8 vs 3.4 ± 1.1 episodes per week; p < 0.01). Reduced glycemic variability and improved treatment satisfaction were also observed.
Conclusions
APS provides superior glycemic control, reduces hypoglycemia, and improves quality of life compared with conventional pump therapy, supporting its clinical relevance in type 1 diabetes management.
Zitieren
APA
Крицький, T. I. (2026). Clinical effectiveness study of the artificial pancreas system (APS) in patients with type 1 diabetes mellitus. Likarska sprava. https://doi.org/10.31640/ls-2026-2-03
Vancouver
Крицький TI. Clinical effectiveness study of the artificial pancreas system (APS) in patients with type 1 diabetes mellitus. Likarska sprava. 2026. doi:10.31640/ls-2026-2-03
BibTeX
@article{2026,
author = {Крицький, T. I.},
title = {Clinical effectiveness study of the artificial pancreas system (APS) in patients with type 1 diabetes mellitus},
journal = {Likarska sprava},
year = {2026},
number = {2},
doi = {10.31640/ls-2026-2-03}
}
EUVIMED